NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
Research & Development
NeoPharm Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Research & Development
-₩3.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
AmorePacific Corp
KRX:090430
|
Research & Development
-₩102.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Amorepacific Group
KRX:002790
|
Research & Development
-₩103.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Cosmax Inc
KRX:192820
|
Research & Development
-₩1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Research & Development
-₩21.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-2%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Research & Development
-₩30.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-36%
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's Research & Development?
Research & Development
-3.5B
KRW
Based on the financial report for Sep 30, 2025, NeoPharm Co Ltd's Research & Development amounts to -3.5B KRW.
What is NeoPharm Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-6%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for NeoPharm Co Ltd have been -6% over the past three years , -4% over the past five years , and -6% over the past ten years .
